Advanced search×

[Regulation of calcium homeostasis by α-Klotho and FGF23].

Clin Calcium 20(11):1677-85 (2010) PMID 21037388

α-klotho was first identified as an aging gene and was later shown to be a regulator of phosphate and vitamin D metabolism, and a regulator of calcium homeostasis. α-kl is expressed in the parathyroid glands, choroid plexus and kidney, where α-Kl binds to Na(+), K(+)-ATPase. Low extracellular calcium concentrations trigger rapid translocation of α-Kl/Na(+), K(+)-ATPase complex from endosomal organella to the plasma membrane. This may lead to the PTH secretion in parathyroid glands and transepithelial transport of calcium in kidney and choroid plexus. FGF members are divided into 7 subfamilies. Among them, metabolic FGF subfamily, consisted of FGF19, FGF21 and FGF23, is characterized as their hormonal effects. Indeed,FGF23 is secreted from bone and is circulated to kidney where FGF23 tranceduces signals that suppress vitamin D synthesis and phosphate reabsorption fgf23 deficient phenotypes were reminiscent of those of mice lacking the α-kl gene, which led us the discovery of molecular interaction and functional crosstalk of α-Kl and FGF23. FGF23 binds to α-Kl and converts the canonical FGF receptor 1c to specific for FGF23 and we proposed a comprehensive regulatory scheme of mineral homeostasis involving the mutually regulated positive/negative feedback actions of α-Kl, FGF23, PTH and 1,25 (OH) (2)D. α-Kl and FGF23 are novel regulators that integrate the fields of mineral homeostasis, life-style related diseases and aging. This newly established field is widely and remarkably progressing and expected to be fruitful.

DOI: CliCa101116771685
Version: za2963e q8zad q8zb8 q8zc2 q8zd2 q8ze9 q8zf6 q8zgf

Similar articles you may find interesting…

  1. The bone histology spectrum in experimental renal failure: adverse effects of phosphate and parathyroid hormone disturbances.

    Calcif Tissue Int 87(1):60-7 (2010) PMID 20428857

    Bone disease is a common disorder of bone remodeling and mineral metabolism, which affects patients with chronic kidney disease. Minor changes in the serum level of a given mineral can trigger compensatory mechanisms, making it difficult to evaluate the role of mineral disturbances i...
  2. Vitamin D: metabolism.

    Endocrinol Metab Clin ... 39(2):243-53, table of contents (2010) PMID 20511049 PMCID PMC2879391

    The biologically active metabolite of vitamin D, 1,25(OH)(2)D(3), affects mineral homeostasis and has numerous other diverse physiologic functions including effects on growth of cancer cells and protection against certain immune disorders. This article reviews the role of vitamin D hydroxylases in p...
  3. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 ve...

    J Clin Endocrinol Metab 95(6):2680-8 (2010) PMID 20392870 PMCID PMC2902068

    Mean predose serum calcium levels were maintained at, or just below, the normal range, and urine calcium levels remained in the normal range throughout the 3-yr study, with no significant differences between treatment groups. Creatinine clearance, corrected for body surface area, did not differ betw...